BM Procedure and Processing
Nuovi farmaci antitrombotici: che cosa cambierà in clinica nei prossimi anni? GF Gensini Livorno 27 marzo 2004.
Hemolytic Anemia and Rh Alloimmunization following Intravenous Immunoglobulin Administration Fang Yin, Peter A. Holt, John A. Nesbitt, Tareq Abou-Khamis,
Allison Weddington, PharmD PGY1 Pharmacy Resident St. Louis Childrens Hospital November 14, 2011 How Much is Too Much? The Use of Rasburicase in the Treatment.
What is MDS MDS comprises a heterogeneous group of clonal haematopoietic stem cell malignancies characterised by 1,2 –BM dysplasia hypercellular BM is.
Red cells from Cord Blood - a new product for the Blood Bank?? Elisabeth Semple, PhD Scientific Director Cells for Life Cord Blood Institute Toronto.
Your Approach to Heart failure and Arrhythmias in Diabetics Dr Mervat Aboulmaaty Professor of Cardiology Ain Shams University 2012.
Neutropénie fébrile Dr S. Alfandari Infectiologue et Hygiéniste, CH Tourcoing Infectiologue du Service des Maladies du sang, CHRU Lille Dr S. Alfandari.
UPFRONT TRANSPLANT IN ALL-HL
Hemolytic anemia
NIH Presentation Nutritional Counseling and Dietetics Practice in Sickle Cell Disease
Fungal infections in hematology patients: advances in prophylaxis and treatment